Judith Bourassa, M.Sc.
About Judith Bourassa, M.Sc.
Judith Bourassa, M.Sc., is an Oncology Therapeutic Specialist at Bristol Myers Squibb in Montreal, Quebec, with extensive experience in oncology and other therapeutic areas.
Current Roles at Bristol Myers Squibb
Judith Bourassa, M.Sc., currently serves as an Oncology Therapeutic Specialist focusing on GI and Lung Cancer at Bristol Myers Squibb in Montreal, Quebec, Canada. In addition to this role, she also works as a Cellular Therapy Specialist in Hematology, particularly in CAR T-cell therapy. These positions reflect her extensive expertise in oncology and cellular therapies.
Previous Positions at Roche
Judith Bourassa has a comprehensive background in oncology from her extensive tenure at Roche. She served as a Senior Therapeutic Specialist in oncology multiple times between 2007 and 2021. Additionally, she held roles as a Medical Science Liaison in oncology from 2016 to 2017 and as a Product Manager from 2014 to 2015. Her early roles at Roche included positions focused on dermatology and cardiology, underscoring her broad therapeutic expertise.
Experience at Baxter International Inc.
Prior to her long-term involvement with Roche, Judith worked at Baxter International Inc. as a Senior Specialist concentrating on Hemophilia and Bleeding Disorders from 2005 to 2007. This role allowed her to develop a specialized focus on hematology-related therapeutic areas, which she later expanded into her oncology work.
Educational Background
Judith holds a Master's Degree in Cell Biology from Université de Sherbrooke, where she studied from 1997 to 2000. She also completed her Bachelor's Degree in Biotechnology from the same institution, spanning 1994 to 1997. Additionally, she pursued studies at the Schulich School of Business - York University in Marketing from 2014 to 2015, further complementing her scientific expertise with business acumen.
Extensive Experience in Oncology
Judith Bourassa has over a decade of experience in the oncology field, holding significant roles at both Roche and Bristol Myers Squibb. At Roche, she transitioned from dermatology to a primary focus on oncology, serving in roles such as Senior Therapeutic Specialist and Product Manager. Her ongoing work at Bristol Myers Squibb continues to build on this extensive oncology background, particularly in GI and Lung Cancer as well as in Cellular Therapy for Hematology.